PharmEvo Pvt Ltd   Report issue

For profit Phase 1 Phase 4
Founded: Karachi Pakistan (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2016
NCT02804386
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Clinision | PharmEvo Private Limited., Pakistan | PharmEvo Pvt Ltd

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Iron-Deficiency (Phase 4)

Asthma (Phase 4)

Atrial Fibrillation (Phase 4)

Common Cold (Phase 4)

Constriction, Pathologic (Phase 4)

Cough (Phase 4)

Hepatitis (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Infertility (Phase 4)

Mitral Valve Stenosis (Phase 4)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 10